StocksMarket.in

Buy Alkem Laboratories; target of Rs 2500: Motilal Oswal

December 06
21:41 2017

Motilal Oswal’s research report on Alkem Laboratories

Alkem Laboratories (ALKEM) has guided for GST -adjusted (impact of ~7%) growth of mid -teens in the domestic market in FY18. This would translate into >20% growth in 2HFY18 (growth will be >25% if we normalize it for GST). Also, in 1QFY19, we expect similar growth levels due to a low base effect (had lost almost one month of sales in 1QFY18 due to GST – related channel destocking).

Outlook

We have upgraded ALKEM to Buy from Neutral, with a target price of INR2,500 @24x December 2019E PER (v/s INR1,950 @ 1HFY20E PER.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Related Articles